宣称 发表于 2025-3-25 05:55:46

http://reply.papertrans.cn/3/227/22615/22615-21.png

perjury 发表于 2025-3-25 09:42:04

http://reply.papertrans.cn/3/227/22615/22615-22.png

种类 发表于 2025-3-25 12:22:22

Submitted on: 10 December 2007.
Revised on: 18 December 2007.
Accepted on: 27 December 2007.
NAR Cancer

事与愿违 发表于 2025-3-25 17:13:47

http://reply.papertrans.cn/3/227/22615/22615-24.png

consent 发表于 2025-3-25 23:45:30

http://reply.papertrans.cn/3/227/22615/22615-25.png

克制 发表于 2025-3-26 03:56:16

http://reply.papertrans.cn/3/227/22615/22615-26.png

Cryptic 发表于 2025-3-26 07:22:35

Submitted on: 26 June 2015.
Revised on: 17 July 2015.
Accepted on: 03 August 2015.
NAR Cancer---OXFORD UNIV PRESS

subordinate 发表于 2025-3-26 08:35:25

Submitted on: 27 December 2008.
Revised on: 05 February 2009.
Accepted on: 27 February 2009.
NAR Cancer

伟大 发表于 2025-3-26 12:39:11

Submitted on: 01 October 2001.
Revised on: 22 October 2001.
Accepted on: 07 November 2001.
NAR Cancer---OXFORD UNIV PRESS

减少 发表于 2025-3-26 18:13:53

http://reply.papertrans.cn/3/227/22615/22615-30.png
页: 1 2 [3] 4
查看完整版本: ESCI期刊NAR Cancer 2024/2025影响因子:3.441 (NAR CANCER) (2632-8674). (BIOCHEMISTRY & MOLECULAR BIOLOGY)(生物化学与分子生物学)Emerging S